Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Agnosia × Yoga × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 21 Fatigue 16 Neoplasms 9 Depression 6 Pain 4 Colorectal Neoplasms 4 Prostatic Neoplasms 3 Glioma 3 Anxiety Disorders 3 Sleep Wake Disorders 2 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Parasomnias 2 Ovarian Neoplasms 2 Oligodendroglioma 2 Obesity 2 Motor Activity 2 Meningioma 2 Medulloblastoma 2 Lymphedema 2 Lung Neoplasms 2 Leukemia 2 Gliosarcoma 2 Glioblastoma 2 Esophageal Neoplasms 2 Ependymoma 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Astrocytoma 2

Interventions

Bupivacaine 9 Ketamine 8 Dexmedetomidine 7 Ropivacaine 6 Fentanyl 6 Anesthesia, General 6 Analgesics, Opioid 6 Acetaminophen 6 Morphine 5 Lidocaine 5 Acupuncture Therapy 5 Tramadol 4 Sodium Chloride 4 Pregabalin 4 Ethanol 4 Anesthesia, Local 4 parecoxib 3 Saline Solution 3 Radiofrequency Ablation 3 Propofol 3 Ketorolac 3 Control Groups 3 Anesthetics, Local 3 Analgesia, Epidural 3 trimebutine 3-thiocarbamoylbenzenesulfonate 2 Transcutaneous Electric Nerve Stimulation 2 Surveys and Questionnaires 2 Oxycodone 2 Magnesium Sulfate 2 Levobupivacaine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05121558 2026-02-06

YCT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡